Lawyer to Finra: Private-placement litigants suffering from 'selective amnesia'

With the sale of private placements facing intense scrutiny from securities regulators, one due diligence attorney has fired off a potent missive to Finra officials about clients' responsibilities when buying the high risk deals.
JUN 29, 2010
With the private-placement sales facing intense scrutiny from securities regulators, one due-diligence attorney has fired off a potent missive to Finra officials about clients’ responsibilities when buying the high-risk investments. In a letter sent last month to James Shorris, Finra's executive director of enforcement, Bryan Mick, president of Mick & Associates PC LLO, said he applauded the Financial Industry Regulatory Authority’s recent efforts to “lower the boom on shady private placements.” But Mr. Mick, whose firm has been scrutinizing private offering for eight years, strongly reminded Mr. Shorris that investors share the risks when buying into such deals. “While customer suitability must remain a primary focus, we perceive that many of these highly sophisticated clients, who are willing to make a higher-risk investment for the potential of high investment returns, are suffering from selective amnesia, and the regulatory agencies are all too eager to be the diagnosing physician,” Mr. Mick said in his letter. Investor losses in private placements have been highlighted by the implosion last summer of deals for Medical Capital Holdings Inc. and Provident Royalties LLC. Both companies were subsequently socked with fraud charges by the Securities and Exchange Commission. State securities regulators have also joined the fray. A complaint filed last month by the Massachusetts Securities Division alleges that independent broker-dealer Securities America Inc. failed to reveal pertinent information to investors about high-risk notes issued by Medical Capital. In December, Mr. Shorris told InvestmentNews that the industry regulator has “a number of investigations under way involving allegations of wrongdoing arising from the sales of these ‘Reg D' private placements,” adding that Finra expected to bring enforcement cases on private placements in 2010. “Reg D” refers to the securities regulations that govern the sale of private-placement investments, which generally don't have to be registered with regulators. Typically, Reg D offerings are conducted by smaller companies. Over the past six months, brokerage executives have routinely said that they are fearful of giving brokers and advisers access to any new private deals in the wake of the Medical Capital and Provident incidents. In his letter to Mr. Shorris, Mr. Mick compared investors who lose money in private placements to those who lose money in the stock market. “If an investor bought Citigroup at $26 and it is now worth $3, the typical reaction is, ‘The bank loaded up on CDOs,' 'Our broker can’t pick bank stocks,' or, 'Management is clueless,’ and the investor takes his lumps,” Mr. Mick wrote. “On the other hand, if the investor loses 80% to 90% or even a fraction of capital in a private placement, the patented approach is, ‘Somebody committed fraud, and I am going to sue them.’” Mr. Mick also pointed out that the overall economy has taken a bite out of private deals, too. “While we encourage regulatory enforcement against truly fraudulent sponsors, we hope that this enforcement is tempered by recognition of economic conditions that have been identified by many macroeconomists as close to those experienced in the Great Depression." He noted that in the midst of the economic meltdown, "investors, plaintiff’s counsel and regulators are quick to label ‘frauds’ and ‘Ponzi schemes’ without fully analyzing the definitional element of such labels.” Finra officials could not comment on the letter, because it relates to Reg D offerings, “the sales of which are the subject of multiple investigations by Finra,” said Herb Perone, a spokesman.

Latest News

Want to get the most out of alts? You’ll have to do your homework
Want to get the most out of alts? You’ll have to do your homework

Advisors who expect an edge from alternatives' illiquidity premium – without understanding the underlying terms and explaining them to clients – have a world of learning to do.

'Finfluencer' Ponzi scheme defrauds investors of over $20M
'Finfluencer' Ponzi scheme defrauds investors of over $20M

The social influencer Tyler Bossetti pleaded guilty to wire fraud and aiding in the filing of false tax documents as a result of the real estate scheme, which ran from 2019 to 2023 and used platforms including Facebook and YouTube.

US annuity sales see sixth straight $100B+ quarter
US annuity sales see sixth straight $100B+ quarter

The latest LIMRA data release shows continued growth in RILAs, variable annuities, and FRD products, though researchers argue more education is still needed.

RIA moves: Thiel's Indivisible welcomes Ride Wealth Partners, $4B Beacon snaps up Astor
RIA moves: Thiel's Indivisible welcomes Ride Wealth Partners, $4B Beacon snaps up Astor

Indivisible Partners builds on its strategy to take turf in the independent space with its latest move in Colorado.

Advisor moves: LPL adds $425M Evermark Investment Partners, $300M Merril Lynch group hops to Ameriprise
Advisor moves: LPL adds $425M Evermark Investment Partners, $300M Merril Lynch group hops to Ameriprise

LPL's latest addition, a San Diego team defecting from RBC, represents a milestone for the broker-dealer giant's Strategic Wealth model for wirehouse breakaways.

SPONSORED RILAs bring stability, growth during volatile markets

Barely a decade old, registered index-linked annuities have quickly surged in popularity, thanks to their unique blend of protection and growth potential—an appealing option for investors looking to chart a steadier course through today's choppy market waters, says Myles Lambert, Brighthouse Financial.

SPONSORED Beyond the dashboard: Making wealth tech human

How intelliflo aims to solve advisors' top tech headaches—without sacrificing the personal touch clients crave